//fpnotebook.com/
Ortho-Novum 1/35
Aka: Ortho-Novum 1/35, Ortho Novum 1/35, Norinyl, Norinyl 1/35, Necon, Dasetta, Alyacen, Nortrel 1/35, Norimin, Pirmella 1/35
- See Also
- Oral Contraceptive
- Oral Contraceptive Drug Interaction
- Oral Contraceptive Selection
- Oral Contraceptive Side Effect Management
- Oral Contraceptive-Related Uterine Bleeding Management
- Preparations (Norethindrone / Ethinyl Estradiol)
- Ortho Novum 1/35, Norinyl 1/35, Nortrel 1/35, Necon, Dasetta or Alyacen
- Norimin (UK)
- Components
- Norethindrone 1.0 mg (see preparations above)
- Ethinyl Estradiol 35 ug
- Effect
- Relative Progestational Activity: 1.0 (moderate)
- Estrogenic Activity: 38 (high)
- Androgenic Activity: 0.34 (moderate)
- Pill associated problems
- Indications to switch to Ortho Cyclen
- Acne Vulgaris (lower androgen)
- Increased Appetite (lower Progestin)
- Major Depression provoked (lower Progestin)
- Indications to switch to Lo/Ovral
- Breast Tenderness or engorgement (lower Estrogen)
- Headaches (lower Estrogen)
- Libido decreased (more androgen)
- Moodiness (less Estrogen or more Progestin)
- Weight gain (less Estrogen or more Progestin)
- Indications to switch to Ortho Novum 7/7/7
- Break-through bleed days 1-9 (more Estrogen)
- Break-through bleed all of month (more Estrogen)
- Menses too light (more Estrogen, less Progestin)
- Indications to switch to Demulen 1/35
- Break-through bleed days 10-21 (more Progestin)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073 [PubMed]
- Speroff (1993) Obstet Gynecol 81:1034-47 [PubMed]
- Dickey (1998) Managing Contraceptive Pill Patients